Skip to main content

Table 1 Clinico-pathologic characteristics of rectal cancer patients

From: The potential predictive value of DEK expression for neoadjuvant chemoradiotherapy response in locally advanced rectal cancer

Characteristics Patients (N = 74)
Median age-years (range) 72 (46–89)
  > 60 years 60 (81%)
  < 60 years 14 (19%)
Sex
 Male 45 (61%)
 Female 29 (39%)
ECOG  
 0 41 (55%)
 1 31 (42%)
 2 2 (3%)
Status  
 Death 7 (10%)
 Alive without disease 59 (78%)
 Alive with disease 7 (10%)
 N/A 1 (1%)
T Downstaging
 0 28 (38%)
 1 39 (53%)
 N/A 7 (9%)
N Downstaging
 0 20 (27%)
 1 47 (64%)
 N/A 7 (9%)
Grade
 Low 19 (26%)
 High 47 (63%)
 N/A 8 (11%)
Stage
 II 4 (6%)
 III 69 (93%)
 N/A 1 (1%)
Neoadjuvant Treatment
 RT + Fluoropyrimidines based 73 (99%)
 Other 1 (1%)
Treatment toxicity
 Yes 30 (41%)
 No 44 (59%)
Pathological Response
 Complete 9 (12%)
 Partial 27 (37%)
 Minimun 38 (51%)
DEK
 Low 26 (35%)
 High 48 (65%)
  1. N/A not available, RT Radiotherapy